This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2003 Remove Pharmacology Remove Safety Related Topics
Pharmaceutical research Side effects Food and Drug Administration Leads Healthcare Doctors Physicians Networking Patients FDA More Related Topics >
article thumbnail

Developing new treatment regimens for HIV

European Pharmaceutical Review

MARCH 11, 2024

With therapeutic expertise in HIV, hepatology and rare diseases, Sherene has additional expertise in clinical pharmacology and drug safety. Sherene has worked in the healthcare sector for more than 20 years, including in several leadership roles at GSK. References 1. World Health Organization. The Global Health Observatory.

Medicine 91
Medicine Pharmacology Healthcare Healthcare 91
article thumbnail

Paving the way for anti-Abeta active immunotherapy

European Pharmaceutical Review

SEPTEMBER 22, 2023

7 It is currently being evaluated in a Phase Ib/IIa clinical study, demonstrating to date a good safety profile. While favourable safety has been reported up to the Phase II, the relevance of targeting the C-terminal portion of Abeta still needs to be confirmed. Andrea Pfeifer, PhD In 2003, Andrea Pfeifer co-founded AC Immune SA.

Food and Drug Administration 78
Food and Drug Administration Safety Patients Leads 78
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024